The Associations Between Gut Length, Gut Microbiota and Food Assimilation
Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · Apr 17, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the length of our intestines, the tiny bacteria living in our gut, and how well we absorb energy from food are all connected. The goal is to understand these relationships better, particularly in healthy individuals. By studying these factors, researchers hope to gain insights that could help with nutrition and managing conditions like metabolic syndrome, which affects how our bodies use energy.
To join this study, participants need to be between 18 and 40 years old, healthy, and without any diseases. They should have a healthy body weight and regular bowel movements. However, people with certain health issues, such as digestive disorders or mental health conditions, or those who have recently taken specific medications, will not be eligible. Participants can expect to provide information about their diet and health, and they may undergo some tests to help researchers gather data. This research is currently seeking volunteers, so if you meet the criteria, you could play a role in advancing our understanding of nutrition and gut health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-40 years old, healthy and disease free.
- • BMI ≥ 18.5;
- • Regular bowel movements.
- Exclusion Criteria:
- • Individuals who are constipated or suffer from intestinal disorders;
- • Individuals with mental illnesses such as depression and claustrophobia;
- • Individuals with glaucoma and prostate hypertrophy;
- • Metal implants in the body;
- • Pregnant and lactating women;
- • Individuals with blood phobia, pathologic hypotension or hypertension;
- • Use of antibiotics, probiotics, oral laxatives within 8 weeks;
- • Individuals with metabolic diseases (e.g., chronic diseases such as diabetes mellitus); recent weight loss due to various medical reasons;
- • Individuals with infectious diseases (e.g. HIV);
- • Irregular diet, lifestyle, addiction to tobacco, alcohol or drugs.
About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences
The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Patients applied
Trial Officials
John R Speakman, PhD
Study Chair
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported